According to the latest report by IMARC Group, titled “Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global vaccine market size reached US$ 41.4 Billion in 2020. On account of the aforementioned factors, the market is anticipated to grow at a CAGR of 8.2% during 2021-2026.
A vaccine stands for a biological component that stimulates antibody production against harmful pathogens in the body. It is typically produced by using disease-causing agents and chemical drugs acting as antigens for preventing diseases. Vaccines are mainly available as inactivated, conjugate, live attenuated, recombinant, and toxoid vaccines. They protect the body against a wide range of various life-threatening diseases, including polio, measles, diphtheria, meningitis, tetanus, etc. As a result, vaccines find widespread applications in several immunization procedures across numerous healthcare facilities and for research purposes in academic and clinical laboratories.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The increasing prevalence of several infectious diseases is one of the primary factors driving the market for vaccines. Moreover, the growing consumer awareness towards effective immunization for eradicating various infections is further augmenting the product demand. Additionally, the introduction of vaccination programs by government bodies across numerous endemic regions is further propelling the market growth. Furthermore, several global organizations, such as the WHO, UNICEF, Bill & Melinda Gates Foundation, etc., are launching adequate vaccination facilities across the developing and under-developed countries. Apart from this, the outbreak of the COVID-19 pandemic, since early 2020, has led to the development of novel vaccines to combat the risk of coronavirus infection. This is expected to further catalyze the growth of the global vaccine market in the coming years.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Abbott Laboratories
Astellas Pharma Inc.
AstraZeneca Plc
Bharat Biotech International Limited
Bavarian Nordic A/S
CSL Limited
Daiichi Sankyo Company, Limited
Emergent BioSolutions Inc.
GlaxoSmithKline Plc
Inovio Pharmaceuticals Inc.
Johnson & Johnson, Inc.
Merck & Co. Inc.
Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
Novavax Inc.
Panacea Biotec Ltd.
Pfizer Inc.
Sanofi Pasteur SA (Sanofi SA)
Serum Institute of India Pvt. Ltd.
Takeda Pharmaceutical Company Limited
Breakup by Technology:
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
Toxoid Vaccines
Others
Breakup by Patient Type:
Paediatric
Adult
Breakup by Indication:
Bacterial Diseases
Meningococcal Disease
Pneumococcal Disease
Diphtheria/Tetanus/Pertussis (DPT)
Tuberculosis
Haemophilus Influenzae (Hib)
Typhoid
Others
Viral Diseases
Hepatitis
Influenza
Human Papillomavirus (HPV)
Measles/Mumps/Rubella (MMR)
Rotavirus
Herpes Zoster
Varicella
Japanese Encephalitis
Rubella
Polio
Rabies
Dengue
Others
Breakup by Route of Administration:
Intramuscular and Subcutaneous Administration
Oral Administration
Others
Breakup by Product Type:
Multivalent Vaccine
Monovalent Vaccine
Breakup by Treatment Type:
Preventive Vaccine
Therapeutic Vaccine
Breakup by End User:
Hospitals
Clinics
Vaccination Centres
Academic and Research Institutes
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Institutional Sales
Others
Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the Report:
Market Performance (2015-2020)
Market Outlook (2021-2026)
COVID-19 Impact on the Market
Porter’s Five Forces Analysis
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Structure of the Market
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group 30 N Gould St, Ste R Sheridan, WY (Wyoming) 82801 USA Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Latest Market Research Reports by IMARC Group (2021-2026):
According to the latest report by IMARC Group, titled “Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global vaccine market size reached US$ 41.4 Billion in 2020. On account of the aforementioned factors, the market is anticipated to grow at a CAGR of 8.2% during 2021-2026.
A vaccine stands for a biological component that stimulates antibody production against harmful pathogens in the body. It is typically produced by using disease-causing agents and chemical drugs acting as antigens for preventing diseases. Vaccines are mainly available as inactivated, conjugate, live attenuated, recombinant, and toxoid vaccines. They protect the body against a wide range of various life-threatening diseases, including polio, measles, diphtheria, meningitis, tetanus, etc. As a result, vaccines find widespread applications in several immunization procedures across numerous healthcare facilities and for research purposes in academic and clinical laboratories.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The increasing prevalence of several infectious diseases is one of the primary factors driving the market for vaccines. Moreover, the growing consumer awareness towards effective immunization for eradicating various infections is further augmenting the product demand. Additionally, the introduction of vaccination programs by government bodies across numerous endemic regions is further propelling the market growth. Furthermore, several global organizations, such as the WHO, UNICEF, Bill & Melinda Gates Foundation, etc., are launching adequate vaccination facilities across the developing and under-developed countries. Apart from this, the outbreak of the COVID-19 pandemic, since early 2020, has led to the development of novel vaccines to combat the risk of coronavirus infection. This is expected to further catalyze the growth of the global vaccine market in the coming years.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Abbott Laboratories
Astellas Pharma Inc.
AstraZeneca Plc
Bharat Biotech International Limited
Bavarian Nordic A/S
CSL Limited
Daiichi Sankyo Company, Limited
Emergent BioSolutions Inc.
GlaxoSmithKline Plc
Inovio Pharmaceuticals Inc.
Johnson & Johnson, Inc.
Merck & Co. Inc.
Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
Novavax Inc.
Panacea Biotec Ltd.
Pfizer Inc.
Sanofi Pasteur SA (Sanofi SA)
Serum Institute of India Pvt. Ltd.
Takeda Pharmaceutical Company Limited
Breakup by Technology:
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
Toxoid Vaccines
Others
Breakup by Patient Type:
Paediatric
Adult
Breakup by Indication:
Bacterial Diseases
Meningococcal Disease
Pneumococcal Disease
Diphtheria/Tetanus/Pertussis (DPT)
Tuberculosis
Haemophilus Influenzae (Hib)
Typhoid
Others
Viral Diseases
Hepatitis
Influenza
Human Papillomavirus (HPV)
Measles/Mumps/Rubella (MMR)
Rotavirus
Herpes Zoster
Varicella
Japanese Encephalitis
Rubella
Polio
Rabies
Dengue
Others
Breakup by Route of Administration:
Intramuscular and Subcutaneous Administration
Oral Administration
Others
Breakup by Product Type:
Multivalent Vaccine
Monovalent Vaccine
Breakup by Treatment Type:
Preventive Vaccine
Therapeutic Vaccine
Breakup by End User:
Hospitals
Clinics
Vaccination Centres
Academic and Research Institutes
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Institutional Sales
Others
Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the Report:
Market Performance (2015-2020)
Market Outlook (2021-2026)
COVID-19 Impact on the Market
Porter’s Five Forces Analysis
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Structure of the Market
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group 30 N Gould St, Ste R Sheridan, WY (Wyoming) 82801 USA Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Latest Market Research Reports by IMARC Group (2021-2026):